Tenascins in fibrotic disorders—from bench to bedside
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Although fibrosis is becoming increasingly recognized as a major cause of morbidity and mortality in chronic inflammatory diseases, available treatment strategies are limited. Tenascins constitute a family of matricellular proteins, primarily modulating interactions of cells with other matrix components and growth factors. Data obtained from tenascin C deficient mice show important roles of this molecule in several models of fibrosis. Moreover there is growing evidence that tenascin C has a strong impact on chronic inflammation, myofibroblast differentiation and recruitment. Tenascin C as well as tenascin X has furthermore been shown to affect TGF-β activation and signaling. Taken together these data suggest that these proteins might be important factors in fibrosis development and make them attractive both as biological markers and as targets for therapeutical intervention. So far most clinical research in fibrosis has been focused on tenascin C. This review aims at summarizing our up-to-date knowledge on the involvement of tenascin C in the pathogenesis of fibrotic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541 · cited 2×
“TGF-b1 production correlates with the progression of liver, lung, kidney, skin and cardiac fibrosis, and inhibition of its signaling pathway has been shown to reduce the development of fibrosis in many experimental models.(1) As an example, overexpression of TGF-b1 by renal tubular epithelial cells results in tubuloin…”
BackgroundThe Extracellular Matrix: Not Just Pretty Fibrils
Hynes, R. O. (2009) · Science · doi:10.1126/science.1176009 · Cited by 3,527 · cited 1×
“Further binding of LAPs to the latent TGF-b–binding proteins (LTBPs) form large latent complexes (LLCs) and allows incorporation of the different latent TGF-b isoforms into extracellular matrices via the LTBPs binding to ECM proteins including fibrillins and fibronectin.(26) Activation of the latent TGF- complex—a cr…”
BackgroundInduction of tenascin in healing wounds
Mackie, E. J., Halfter, W., & Liverani, D. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.6.2757 · Cited by 555
Tenascin-X deficiency is associated with Ehlers-Danlos syndrome
Burch, G. H., Gong, Y., Liu, W., Dettman, R. W., Curry, C. J., Smith, L., Miller, W. L., & Bristow, J. (1997) · Nature Genetics · doi:10.1038/ng0997-104 · Cited by 366 · cited 1×
“Tenascins and collagen synthesis A crucial role for tenascin X in collagen biology is suggested by the fact that its deficiency is associated with Ehlers-Danlos syndrome in humans.(29) Major clinical symptoms consist of skin hyperextensibility and joint laxity, while ultrastructural analyses reveal abnormalities in co…”
BackgroundMao, J. R., Taylor, G., Dean, W. B., Wagner, D. R., Afzal, V., Lotz, J. C., Rubin, E. M., & Bristow, J. (2002) · Nature Genetics · doi:10.1038/ng850 · Cited by 261 · cited 1×
“Mice deficient in tenascin X partly reproduced this phenotype.(30) In vitro studies revealed that tenascin X interacts with fibrillar collagen type I, III and V when they are in native conformation.”
BackgroundTenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β
Alcaraz, L. B., Exposito, J.-Y., Chuvin, N., Pommier, R. M., Cluzel, C., Martel, S., Sentis, S., Bartholin, L., Lethias, C., & Valcourt, U. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201308031 · Cited by 94
A model of tenascin-X integration within the collagenous network
Lethias, C., Carisey, A., Comte, J., Cluzel, C., & Exposito, J.-Y. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.037 · Cited by 74
Distinct Tissue Distribution in Pigs of Tenascin‐X and Tenascin‐C Transcripts
Geffrotin, C., Garrido, J. J., Tremet, L., & Vaiman, M. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0083f.x · Cited by 72
Cited by
The big five in fibrosis: Macrophages, myofibroblasts, matrix, mechanics, and miscommunication
Pakshir, P., & Hinz, B. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.019 · Cited by 396
Noninvasive proteomic biomarkers for alcohol-related liver disease
Niu, L., Thiele, M., Geyer, P. E., Rasmussen, D. N., Webel, H. E., Santos, A., Gupta, R., Meier, F., Strauss, M., Kjaergaard, M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01850-y · Cited by 309
Tenascin-C drives persistence of organ fibrosis
Bhattacharyya, S., Wang, W., Morales-Nebreda, L., Feng, G., Wu, M., Zhou, X., Lafyatis, R., Lee, J., Hinchcliff, M., Feghali-Bostwick, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms11703 · Cited by 292
It’s all about the spaces between cells: role of extracellular matrix in liver fibrosis
Khurana, A., Sayed, N., Allawadhi, P., & Weiskirchen, R. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-2948 · Cited by 79
Cardiac Fibroblasts and the Extracellular Matrix in Regenerative and Nonregenerative Hearts
Hortells, L., Johansen, A. K. Z., & Yutzey, K. E. (2019) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd6030029 · Cited by 79
Metadata
- Authors
- Kasprzycka, M., Hammarström, C., & Haraldsen, G.
- Venue
- Cell Adhesion & Migration
- Publisher
- Informa UK Limited
- Published
- 2015-01-02
- Volume
- 9
- Issue
- 1-2
- Pages
- 83-89
- ISSN
- 1933-6918 (ISSN-L)
- 1933-6926
- OpenAlex
- W2171930491
- Cited by
- 56
- References
- 8
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tenascins in fibrotic disorders—from bench to bedside. https://app.cochat.ai/papers/10.4161/19336918.2014.994901
- The paper
- Kasprzycka, M., Hammarström, C., & Haraldsen, G. (2015). Tenascins in fibrotic disorders—from bench to bedside. Cell Adhesion & Migration. https://doi.org/10.4161/19336918.2014.994901
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.